-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
Achilles Therapeutics plc quarterly Common Stock, Value, Issued history and growth rate from Q4 2020 to Q2 2024.
- Achilles Therapeutics plc Common Stock, Value, Issued for the quarter ending June 30, 2024 was $54K, unchanged year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)